An in vitro diagnostic to aid in the diagnosis of inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis, and to differentiate IBD from irritable bowel syndrome (IBS) in conjunction with other clinical and laboratory findings.
Screw cap plastic container (non sterile)
Frozen (preferred) - 4 months
Freeze/Thaw cycles stable x3
Refrigerated - 3 days
Ambient - 2 days
Quantitative enzyme-linked immunosorbent assay (ELISA)
Concentration |
Interpretation |
Follow-up |
< 16 − 50 μg/g |
Normal |
None |
> 50 − 120 μg/g |
Borderline |
Re-evaluate in 4 - 6 weeks |
> 120 μg/g |
Abnormal |
Repeat as clinically indicated |